$BBTX
Bambusa Therapeutics, Inc.
Nasdaq · Biological Products, (No Diagnostic Substances) · Boston, MA
BBTX chart
What traders are saying about $BBTX
Latest postsBambusa Therapeutics, Inc. news
- Bambusa Therapeutics IPO raises $168.9M on Nasdaq - Bizwomen
The Business Journals ·
- Discontinued operations of Bambusa Therapeutics, Inc. – NASDAQ:BBTX
TradingView ·
- RA Capital Reveals 14.6% Stake in Bambusa Therapeutics Post-IPO Filing
Kalkine Media ·
- Bambusa Therapeutics, Inc. (BBTX) recent insider transactions
Yahoo Finance UK ·
- Bambusa Therapeutics, Inc. (BBTX) latest press releases and corporate news
Yahoo Finance UK ·
- Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering
Yahoo Finance ·
Bambusa Therapeutics, Inc. key financials
No XBRL financial data is available for this company yet.
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Bambusa Therapeutics, Inc.
- Ticker
- BBTX (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 2044950
Frequently asked questions
What exchange is Bambusa Therapeutics, Inc. listed on?
Bambusa Therapeutics, Inc. trades on the Nasdaq under the ticker symbol BBTX.
What industry is Bambusa Therapeutics, Inc. in?
Bambusa Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)".
Where is Bambusa Therapeutics, Inc. headquartered?
Bambusa Therapeutics, Inc.'s business address on file with the SEC is in Boston, MA.
When does Bambusa Therapeutics, Inc.'s fiscal year end?
Bambusa Therapeutics, Inc.'s fiscal year ends on December 31.